FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 72550

News■ Unclear/unknown

TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer

KINDNews
DIRECTION■ Unclear/unknown
SOURCES2
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-09 06:56 UTC
LAST UPDATE2026-10-09 07:00 UTC
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

CEO transition at small biotech is routine governance news with minimal market transmission.

Routine biotech leadership transition
CATALYST TO WATCH

New CEO strategic announcements

MAIN RISK

Strategy shift could unsettle investors

FULL DISPATCH

Rolf Sass Sørensen succeeds co-founder Martin Rose. Founders Martin Rose and Jesper Breum move on to pursue new biotech ventures while remaining shareholders in TETRAPHARM. COPENHAGEN, Denmark, Oct. 9, 2026 /PRNewswire/ -- TETRAPHARM has appointed Rolf Sass Sørensen as Chief Executive...

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

2 SOURCES CONFIRMED
№ 01prnewswireprnewswire.com · CONFIRMING2026-10-09 07:00 UTCOPEN RECEIPT →
№ 02prnewswireprnewswire.com · PRIMARY2026-10-09 06:56 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.